Cohesion Technologies launches CoStasis in Europe
This article was originally published in Clinica
Cohesion Technologies has launched its surgical haemostat, CoStasis, in Austria, Germany and the UK. By the summer, the Palo Alto, California-based company plans to introduce the product in Belgium, Denmark, Finland, France, Italy, the Netherlands, Norway, Portugal and Spain.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.